Pfizer (PFE) Common Equity (2009 - 2026)
Pfizer (PFE) recorded Common Equity of $85.49 billion in Q2 2026, down 4.0% from $89.01 billion a year earlier and down 5.4% from the prior quarter.
Powered by 
Analysis
Pfizer (PFE) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Pfizer reported Common Equity of $86.78 billion, down 1.9% from FY2024.
- Annual Common Equity has declined for three straight years, though with a five-year compound annual growth rate of 6.5% (FY2020 to FY2025).
- Across earlier years, Common Equity came in at $88.5 billion in FY2024 (-0.9%), $89.29 billion in FY2023 (-6.9%), $95.92 billion in FY2022 (+23.8%) and $77.46 billion in FY2021 (+22.0%).
- The Q2 2026 figure is the lowest quarterly Common Equity since Q1 2022.
- On a year-over-year basis, Common Equity has declined for three consecutive quarters, with an average decline of 1.1% over the last seven quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 24.4% in Q2 2022, against a decline of 11.4% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $90.4 billion (Q1 2026), $86.78 billion (Q4 2025) and $93.1 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Bristol Myers Squibb | 127.55 Bn | 78.82 Bn | 9.25 Bn | 22.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 85.49 Bn |
| Mar 29, 2026 | 90.40 Bn |
| Dec 31, 2025 | 86.78 Bn |
| Sep 28, 2025 | 93.10 Bn |
| Jun 29, 2025 | 89.01 Bn |
| Mar 30, 2025 | 90.64 Bn |
| Dec 31, 2024 | 88.50 Bn |
| Sep 29, 2024 | 92.56 Bn |
| Jun 30, 2024 | 87.98 Bn |
| Mar 31, 2024 | 92.56 Bn |
| Dec 31, 2023 | 89.29 Bn |
| Sep 30, 2023 | 20.97 Bn |
| Jul 2, 2023 | 99.29 Bn |
| Apr 2, 2023 | 101.24 Bn |
| Dec 31, 2022 | 95.92 Bn |
| Sep 30, 2022 | 18.68 Bn |
| Jul 3, 2022 | 87.47 Bn |
| Apr 3, 2022 | 82.69 Bn |
| Dec 31, 2021 | 77.46 Bn |
| Oct 3, 2021 | 75.97 Bn |
API Access
Pfizer Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PFE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PFE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PFE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();